vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Excelerate Energy, Inc. (EE). Click either name above to swap in a different company.

Excelerate Energy, Inc. is the larger business by last-quarter revenue ($317.6M vs $205.4M, roughly 1.5× COLLEGIUM PHARMACEUTICAL, INC). On growth, Excelerate Energy, Inc. posted the faster year-over-year revenue change (15.7% vs 12.9%). Over the past eight quarters, Excelerate Energy, Inc.'s revenue compounded faster (26.0% CAGR vs 19.1%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Excelerate Energy, Inc. is a global leading provider of flexible liquefied natural gas (LNG) solutions, offering floating storage and regasification units, LNG delivery services and integrated infrastructure projects. It serves utility and industrial clients across Europe, Asia, Latin America and the Middle East, supporting markets to achieve accessible low-carbon energy transitions.

COLL vs EE — Head-to-Head

Bigger by revenue
EE
EE
1.5× larger
EE
$317.6M
$205.4M
COLL
Growing faster (revenue YoY)
EE
EE
+2.7% gap
EE
15.7%
12.9%
COLL
Faster 2-yr revenue CAGR
EE
EE
Annualised
EE
26.0%
19.1%
COLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
EE
EE
Revenue
$205.4M
$317.6M
Net Profit
$17.0M
Gross Margin
62.5%
Operating Margin
29.6%
22.2%
Net Margin
8.3%
Revenue YoY
12.9%
15.7%
Net Profit YoY
35.3%
EPS (diluted)
$0.48
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
EE
EE
Q4 25
$205.4M
$317.6M
Q3 25
$209.4M
$391.0M
Q2 25
$188.0M
$204.6M
Q1 25
$177.8M
$315.1M
Q4 24
$181.9M
$274.6M
Q3 24
$159.3M
$193.4M
Q2 24
$145.3M
$183.3M
Q1 24
$144.9M
$200.1M
Net Profit
COLL
COLL
EE
EE
Q4 25
$17.0M
Q3 25
$31.5M
Q2 25
$12.0M
Q1 25
$2.4M
Q4 24
$12.5M
Q3 24
$9.3M
Q2 24
$19.6M
Q1 24
$27.7M
Gross Margin
COLL
COLL
EE
EE
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
Q3 24
60.8%
Q2 24
62.5%
Q1 24
63.1%
Operating Margin
COLL
COLL
EE
EE
Q4 25
29.6%
22.2%
Q3 25
29.7%
22.3%
Q2 25
18.7%
21.2%
Q1 25
12.2%
20.9%
Q4 24
20.9%
21.9%
Q3 24
21.9%
30.9%
Q2 24
32.7%
27.2%
Q1 24
34.1%
22.6%
Net Margin
COLL
COLL
EE
EE
Q4 25
8.3%
Q3 25
15.0%
Q2 25
6.4%
Q1 25
1.4%
Q4 24
6.9%
Q3 24
5.9%
Q2 24
13.5%
Q1 24
19.1%
EPS (diluted)
COLL
COLL
EE
EE
Q4 25
$0.48
$0.24
Q3 25
$0.84
$0.43
Q2 25
$0.34
$0.15
Q1 25
$0.07
$0.46
Q4 24
$0.36
$0.42
Q3 24
$0.27
$0.35
Q2 24
$0.52
$0.26
Q1 24
$0.71
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
EE
EE
Cash + ST InvestmentsLiquidity on hand
$386.7M
$538.2M
Total DebtLower is stronger
$936.3M
Stockholders' EquityBook value
$301.7M
$2.2B
Total Assets
$1.7B
$4.1B
Debt / EquityLower = less leverage
0.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
EE
EE
Q4 25
$386.7M
$538.2M
Q3 25
$285.9M
$462.6M
Q2 25
$222.2M
$426.0M
Q1 25
$197.8M
$619.5M
Q4 24
$162.8M
$537.5M
Q3 24
$120.0M
$608.4M
Q2 24
$271.6M
$609.1M
Q1 24
$318.0M
$578.9M
Total Debt
COLL
COLL
EE
EE
Q4 25
$936.3M
Q3 25
$942.0M
Q2 25
$946.2M
Q1 25
$322.6M
Q4 24
$333.6M
Q3 24
$345.7M
Q2 24
$356.4M
Q1 24
$366.9M
Stockholders' Equity
COLL
COLL
EE
EE
Q4 25
$301.7M
$2.2B
Q3 25
$274.8M
$2.2B
Q2 25
$232.2M
$2.1B
Q1 25
$234.4M
$1.9B
Q4 24
$228.8M
$1.9B
Q3 24
$234.3M
$1.9B
Q2 24
$216.6M
$1.8B
Q1 24
$222.2M
$1.8B
Total Assets
COLL
COLL
EE
EE
Q4 25
$1.7B
$4.1B
Q3 25
$1.6B
$4.1B
Q2 25
$1.6B
$4.0B
Q1 25
$1.6B
$2.9B
Q4 24
$1.7B
$2.9B
Q3 24
$1.6B
$2.9B
Q2 24
$1.1B
$2.9B
Q1 24
$1.1B
$2.9B
Debt / Equity
COLL
COLL
EE
EE
Q4 25
0.42×
Q3 25
0.43×
Q2 25
0.44×
Q1 25
0.17×
Q4 24
0.18×
Q3 24
0.18×
Q2 24
0.19×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
EE
EE
Operating Cash FlowLast quarter
$123.0M
$104.4M
Free Cash FlowOCF − Capex
$122.4M
FCF MarginFCF / Revenue
59.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
EE
EE
Q4 25
$123.0M
$104.4M
Q3 25
$78.4M
$114.9M
Q2 25
$72.4M
$87.1M
Q1 25
$55.4M
$154.8M
Q4 24
$84.6M
$49.6M
Q3 24
$-9.0M
$39.8M
Q2 24
$67.4M
$90.4M
Q1 24
$61.9M
$64.7M
Free Cash Flow
COLL
COLL
EE
EE
Q4 25
$122.4M
Q3 25
$78.3M
Q2 25
$72.4M
Q1 25
$54.6M
Q4 24
$84.1M
Q3 24
$-9.2M
Q2 24
$67.1M
Q1 24
$61.4M
FCF Margin
COLL
COLL
EE
EE
Q4 25
59.6%
Q3 25
37.4%
Q2 25
38.5%
Q1 25
30.7%
Q4 24
46.2%
Q3 24
-5.8%
Q2 24
46.2%
Q1 24
42.3%
Capex Intensity
COLL
COLL
EE
EE
Q4 25
0.3%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.4%
Q4 24
0.3%
Q3 24
0.2%
Q2 24
0.2%
Q1 24
0.4%
Cash Conversion
COLL
COLL
EE
EE
Q4 25
7.25×
Q3 25
2.49×
Q2 25
6.05×
Q1 25
22.92×
Q4 24
6.75×
Q3 24
-0.96×
Q2 24
3.44×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

EE
EE

Other$179.4M57%
Revenue From Leases$138.1M43%

Related Comparisons